Laboratory Corporation of America Holdings v. Qiagen Sciences, LLC, No. 23-2350 (Fed. Cir. Aug. 13, 2025)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Qiagen Sciences, LLC and others1 (collectively “Qi- agen”) appeal from a final judgment of the United States District Court for the District of Delaware following a jury trial. The jury awarded Laboratory Corporation of Amer- ica Holdings, Labcorp Genetics, Inc., and The General Hos- pital Corporation (collectively, “ Appellees”)2 damages for infringement of its U.S. Patent 10,017,810 (“the ’810 pa- tent”) and U.S. Patent 10,450,597 (“the ’597 patent”). See J.A. 73–77.